101 related articles for article (PubMed ID: 12591008)
1. Role of metoprolol, B1-adrenoceptor antagonist, thromboxane A2 and nitric oxide in CsA-induced hypertension.
Oriji GK
Prostaglandins Leukot Essent Fatty Acids; 2003 Mar; 68(3):233-8. PubMed ID: 12591008
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide in CsA-induced hypertension: role of beta-adrenoceptor antagonist and thromboxane A2.
Oriji GK; Schanz N
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):259-63. PubMed ID: 11993718
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C.
Oriji GK; Keiser HR
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1091-7. PubMed ID: 10604485
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide in cyclosporine A-induced hypertension.
Oriji GK; Keiser HR
Hypertension; 1998 Nov; 32(5):849-55. PubMed ID: 9822443
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide in cyclosporine A-induced hypertension: endothelin receptors gene expression.
Oriji GK
Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):41-4. PubMed ID: 10477041
[TBL] [Abstract][Full Text] [Related]
6. Metoprolol ameliorates cyclosporine a-induced hypertension and nephrotoxicity in rats.
El-Gowilly SM
J Cardiovasc Pharmacol; 2011 Dec; 58(6):639-46. PubMed ID: 21885994
[TBL] [Abstract][Full Text] [Related]
7. Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions.
Nasser SA; Elmallah AI; Sabra R; Khedr MM; El-Din MM; El-Mas MM
Eur J Pharmacol; 2014 Mar; 727():52-9. PubMed ID: 24486390
[TBL] [Abstract][Full Text] [Related]
8. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension.
Vaziri ND; Ni Z; Zhang YP; Ruzics EP; Maleki P; Ding Y
Kidney Int; 1998 Aug; 54(2):482-91. PubMed ID: 9690215
[TBL] [Abstract][Full Text] [Related]
9. Curative isosorbide-5-mononitrate treatment, in opposition to the beneficial preventive one, aggravates the prothrombotic and proconstrictor state in cyclosporine-induced hypertensive rats.
Reis F; Ponte L; Rocha L; Teixeira-Lemos E; Almeida L; Alcobia T; Lourenço M; Palmeiro A; Ferrer-Antunes CA; Costa-Almeida C; Teixeira F
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):640-8. PubMed ID: 16120191
[TBL] [Abstract][Full Text] [Related]
10. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
[TBL] [Abstract][Full Text] [Related]
11. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Hagar HH; El Etter E; Arafa M
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
[TBL] [Abstract][Full Text] [Related]
12. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
Bader FM; Hagan ME; Crompton JA; Gilbert EM
J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
[TBL] [Abstract][Full Text] [Related]
13. Changes in the cardiovascular nitric oxide pathway in cyclosporin-A treated rats.
Rao MR; Hutcheson AE; Markov AK
Drug Chem Toxicol; 1998 Feb; 21(1):27-34. PubMed ID: 9530528
[TBL] [Abstract][Full Text] [Related]
14. Impairment of vascular and platelet levels of nitric oxide and cyclic guanosine-3',5'-monophosphate in cyclosporin A-induced hypertensive rats.
Santiago M; Reis F; Almeida L; Alcobia T; Dionísio J; Teixeira F
Fundam Clin Pharmacol; 2003 Feb; 17(1):43-50. PubMed ID: 12588629
[TBL] [Abstract][Full Text] [Related]
15. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
Maeso R; Rodrigo E; Muñoz-Garcia R; Navarro-Cid J; Ruilope LM; Lahera V; Cachofeiro V
J Hypertens; 1997 Dec; 15(12 Pt 2):1677-84. PubMed ID: 9488222
[TBL] [Abstract][Full Text] [Related]
16. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Chander V; Chopra K
Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation.
Lee J; Kim SW; Kook H; Kang DG; Kim NH; Choi KC
Nephrol Dial Transplant; 1999 Nov; 14(11):2634-8. PubMed ID: 10534504
[TBL] [Abstract][Full Text] [Related]
18. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
Reis F; Teixeira de Lemos E; Almeida L; Parada B; Garrido AP; Rocha-Pereira P; Santos-Silva A; Santos-Dias J; Dinis A; Figueiredo A; Costa-Almeida C; Mota A; Teixeira F
Transplant Proc; 2007 Oct; 39(8):2501-6. PubMed ID: 17954158
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
[TBL] [Abstract][Full Text] [Related]
20. Allicin ameliorates kidney function and urinary bladder sensitivity in cyclosporine A-treated rats.
El-Kashef DH; El-Kenawi AE; Suddek GM; Salem HA
Hum Exp Toxicol; 2017 Jul; 36(7):681-691. PubMed ID: 27596067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
